publication venue for
- Are we there yet? A machine learning architecture to predict organotropic metastases.. 14. 2021
- Genome-wide copy number variations in a large cohort of bantu African children.. 14. 2021
- Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.. 13. 2020
- New insights into DNA methylation signatures: SMARCA2 variants in Nicolaides-Baraitser syndrome.. 12. 2019
- Sequencing and curation strategies for identifying candidate glioblastoma treatments.. 12. 2019
- A PheWAS study of a large observational epidemiological cohort of African Americans from the REGARDS study.. 12. 2019
- A method to reduce ancestry related germline false positives in tumor only somatic variant calling.. 10. 2017
- Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.. 10. 2017
- Associations of circulating plasma microRNAs with age, body mass index and sex in a population-based study.. 8. 2015
- ASEQ: fast allele-specific studies from next-generation sequencing data.. 8. 2015
- Genes associated with MUC5AC expression in small airway epithelium of human smokers and non-smokers.. 5. 2012
- Genome-wide joint SNP and CNV analysis of aortic root diameter in African Americans: the HyperGEN study.. 4. 2011
- CNAReporter: a GenePattern pipeline for the generation of clinical reports of genomic alterations.. 3. 2010
- Molecular sampling of prostate cancer: a dilemma for predicting disease progression.. 3. 2010
- Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation.. 2. 2009
- Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status.. 1. 2008
- Correction to: Sequencing and curation strategies for identifying candidate glioblastoma treatments.. 12. 2019
- Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways. 2015